BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16417524)

  • 1. Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha.
    Srinivas H; Xia D; Moore NL; Uray IP; Kim H; Ma L; Weigel NL; Brown PH; Kurie JM
    Biochem J; 2006 May; 395(3):653-62. PubMed ID: 16417524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of the tumor suppressor gene retinoic acid receptor beta2 through the phosphoinositide 3-kinase/Akt signaling pathway.
    Lefebvre B; Brand C; Flajollet S; Lefebvre P
    Mol Endocrinol; 2006 Sep; 20(9):2109-21. PubMed ID: 16613989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha.
    Srinivas H; Juroske DM; Kalyankrishna S; Cody DD; Price RE; Xu XC; Narayanan R; Weigel NL; Kurie JM
    Mol Cell Biol; 2005 Feb; 25(3):1054-69. PubMed ID: 15657432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
    Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
    Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
    Wan H; Hong WK; Lotan R
    Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic retinoid Am80 inhibits interaction of KLF5 with RAR alpha through inducing KLF5 dephosphorylation mediated by the PI3K/Akt signaling in vascular smooth muscle cells.
    Zhang XH; Zheng B; Han M; Miao SB; Wen JK
    FEBS Lett; 2009 Apr; 583(8):1231-6. PubMed ID: 19292987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells.
    Gianni M; Peviani M; Bruck N; Rambaldi A; Borleri G; Terao M; Kurosaki M; Paroni G; Rochette-Egly C; Garattini E
    Leukemia; 2012 Aug; 26(8):1850-61. PubMed ID: 22354283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-specific inhibition of retinoic acid receptor-alpha silencing by the AF2/tau c activation domain can be overcome by the corepressor SMRT, but not by N-CoR.
    Baniahmad A; Dressel U; Renkawitz R
    Mol Endocrinol; 1998 Apr; 12(4):504-12. PubMed ID: 9544986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of the retinoic acid receptor-alpha by protein kinase A.
    Rochette-Egly C; Oulad-Abdelghani M; Staub A; Pfister V; Scheuer I; Chambon P; Gaub MP
    Mol Endocrinol; 1995 Jul; 9(7):860-71. PubMed ID: 7476969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation by PKA potentiates retinoic acid receptor alpha activity by means of increasing interaction with and phosphorylation by cyclin H/cdk7.
    Gaillard E; Bruck N; Brelivet Y; Bour G; Lalevée S; Bauer A; Poch O; Moras D; Rochette-Egly C
    Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9548-53. PubMed ID: 16769902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Jun N-terminal kinase activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of retinoic acid receptor α protein in hepatic cells.
    Hoshikawa Y; Kanki K; Ashla AA; Arakaki Y; Azumi J; Yasui T; Tezuka Y; Matsumi Y; Tsuchiya H; Kurimasa A; Hisatome I; Hirano T; Fujimoto J; Kagechika H; Shomori K; Ito H; Shiota G
    Cancer Sci; 2011 May; 102(5):934-41. PubMed ID: 21272161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
    Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of highly potent retinoic acid receptor alpha-selective antagonists.
    Teng M; Duong TT; Johnson AT; Klein ES; Wang L; Khalifa B; Chandraratna RA
    J Med Chem; 1997 Aug; 40(16):2445-51. PubMed ID: 9258350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1.
    Darby TG; Meissner JD; Rühlmann A; Mueller WH; Scheibe RJ
    Oncogene; 1997 Dec; 15(25):3067-82. PubMed ID: 9444955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic cytotoxicity exhibited by combination treatment of selective retinoid ligands with taxol (Paclitaxel).
    Vivat-Hannah V; You D; Rizzo C; Daris JP; Lapointe P; Zusi FC; Marinier A; Lorenzi MV; Gottardis MM
    Cancer Res; 2001 Dec; 61(24):8703-11. PubMed ID: 11751388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
    Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
    Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
    Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
    EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct actions of retinoid-receptor ligands.
    Chen JY; Clifford J; Zusi C; Starrett J; Tortolani D; Ostrowski J; Reczek PR; Chambon P; Gronemeyer H
    Nature; 1996 Aug; 382(6594):819-22. PubMed ID: 8752277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
    Agadir A; Shealy YF; Hill DL; Zhang X
    Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.